Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013

Technology Transfer

26 Jun 2013 - 28 Jun 2013 - London, UK

Bookmark and Share

This three-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring manufacturing technology and to highlight some proven techniques for overcoming those challenges.

The focus of the course is on small-molecules and their formulations rather than biological products, although many of the issues faced and techniques discussed will be equally applicable.

Some of the benefits to be derived from this workshop include:

  • An appreciation of where TT fits in the life cycle of a pharmaceutical product.
  • An appreciation of the importance of planning and project management in TT
  • An overview of the potential complexity of technology and product transfer.
  • An outline of proven best practice in technology transfer.
  • An opportunity to discuss current issues and challenges in technology transfer with peers and with an expert faculty.
  • A consideration of 'where next' as we move from traditionally-developed products to a world where products are developed using QbD techniques and controlled by PAT.

Who Should Attend?

Pharmaceutical technologists, Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and anybody else involved in the transfer of products or technology from one location to another.

Course Programme

Day 1

Why Transfer Technology?

Pharmaceutical Product Life Cycle

  • Development
  • Innovative
  • Mature
  • Generic

Product Transfers and Technology Transfers

  • IP
  • Technology
  • Techniques
  • Regulatory Considerations

Registration Procedures

  • Europe
  • Non-European

Variation Procedures

  • Types of Variations
  • Advantages and Disadvantages

Day 2

Technical Challenges

  • Manufacturing processes
  • Validation
  • Stability
  • Packaging processes

Logistical Challenges

  • Label Changes * Text * Physical
  • Timing * Project Plan * Phase in/out

Day 3

Technical Challenges (2)

Impact of new technology

  •  Quality by Design
  •  Process Analytical Technology

Human Challenges

  • Push versus Pull
  • Team membership and team roles
  • Cross-Cultural Issues
  • Progress Reporting and breaking bad news

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos